A Novel Inflammatory Signal in Pulmonary Neutrophilia
肺中性粒细胞增多症中的一种新炎症信号
基本信息
- 批准号:6936298
- 负责人:
- 金额:$ 3.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:biological signal transductioncell linechemoattractantschemokinechemokine receptorchemotaxisclinical researchcollagenendotoxinsenvironmental exposureflow cytometryhuman subjectimmune responseimmunopathologyinflammationinterleukin 8laboratory mouselipopolysaccharidesmonoclonal antibodyneutrophilnitrogen oxidesozonepredoctoral investigator
项目摘要
DESCRIPTION (provided by applicant): Breakdown of collagen releases a tripeptide, PGP, that is chemotactic for neutrophils (PMN) in vitro. It is shown here that airway exposure to PGP causes a robust, exclusive influx of PMN, cells critical in respiratory pathology. Chronic airway exposure to this peptide recapitulates certain aspects of airway disease. Furthermore, using mass spectrometry, PGP is found in the airways of animals acutely exposed to aerosolized endotoxin and contributes to PMN chemotactic activity. The PMN chemotactic activity of PGP may be due to a marked structural relatedness to a receptor binding domain of CXC chemokines specific for PMN such as IL-8, which contain this collagen sequence or a close analog. An antagonist developed by our laboratory, termed RTR, binds PGP in solution and blocks its in vitro and in vivo effects. Likely as a result of shared structure with PGP, RTR also blocks IL-8 activity. Thus the overall goals of this proposal are to: 1) characterize the activity of PGP on PMN; 2) determine if PGP's effects are mediated through actions on chemokine receptors; and 3) determine whether PGP or a related molecule is generated in vivo and signals PMN in animal models of environmentally mediated airway inflammation like ozone exposure.
描述(由申请方提供):胶原蛋白分解释放三肽PGP,其在体外对中性粒细胞(PMN)具有趋化性。这里显示,气道暴露于PGP导致PMN(在呼吸病理学中至关重要的细胞)的强有力的排他流入。慢性气道暴露于这种肽重现了气道疾病的某些方面。此外,使用质谱法,发现PGP存在于急性暴露于雾化内毒素的动物的气道中,并有助于PMN趋化活性。PGP的PMN趋化活性可能是由于与PMN特异性的CXC趋化因子(如IL-8)的受体结合结构域的显著结构相关性,所述CXC趋化因子含有这种胶原序列或类似物。我们实验室开发的一种拮抗剂,称为RTR,在溶液中结合PGP并阻断其体外和体内作用。可能由于与PGP共享结构,RTR也阻断IL-8活性。因此,本提案的总体目标是:1)表征PGP对PMN的活性; 2)确定PGP的作用是否通过对趋化因子受体的作用介导;以及3)确定PGP或相关分子是否在体内产生并在环境介导的气道炎症(如臭氧暴露)的动物模型中向PMN发出信号。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NATHANIEL M WEATHINGTON其他文献
NATHANIEL M WEATHINGTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NATHANIEL M WEATHINGTON', 18)}}的其他基金
Macrophage Immunometabolism alteration by intense beta agonist therapy.
强β激动剂治疗改变巨噬细胞免疫代谢。
- 批准号:
10002645 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
Derangement of alveolar macrophage immunuometabolism by prolonged beta agonist therapy: Implications for host defense and tissue health
长期β受体激动剂治疗引起的肺泡巨噬细胞免疫代谢紊乱:对宿主防御和组织健康的影响
- 批准号:
9791199 - 财政年份:2018
- 资助金额:
$ 3.04万 - 项目类别:
Cellular regulation of the IL-22 receptor and its importance in lung immunity.
IL-22 受体的细胞调节及其在肺免疫中的重要性。
- 批准号:
9185338 - 财政年份:2014
- 资助金额:
$ 3.04万 - 项目类别:
Cellular regulation of the IL-22 receptor and its importance in lung immunity.
IL-22 受体的细胞调节及其在肺免疫中的重要性。
- 批准号:
8970720 - 财政年份:2014
- 资助金额:
$ 3.04万 - 项目类别:
Cellular regulation of the IL-22 receptor and its importance in lung immunity.
IL-22 受体的细胞调节及其在肺免疫中的重要性。
- 批准号:
8805079 - 财政年份:2014
- 资助金额:
$ 3.04万 - 项目类别:
A Novel Inflammatory Signal in Pulmonary Neutrophilia
肺中性粒细胞增多症中的一种新炎症信号
- 批准号:
7049484 - 财政年份:2005
- 资助金额:
$ 3.04万 - 项目类别:
A Novel Inflammatory Signal in Pulmonary Neutrophilia
肺中性粒细胞增多症中的一种新炎症信号
- 批准号:
7217286 - 财政年份:2005
- 资助金额:
$ 3.04万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 3.04万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 3.04万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 3.04万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 3.04万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 3.04万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 3.04万 - 项目类别:
Studentship